title: Reduction in serum concentrations of ciprofloxacin after administration of ursodiol to a patient with hepatobiliary disease.
authors.forename: P P
authors.initials: PP
authors.lastname: Belliveau
authors.forename: C H
authors.initials: CH
authors.lastname: Nightingale
authors.forename: R
authors.initials: R
authors.lastname: Qunitiliani
authors.forename: E G
authors.initials: EG
authors.lastname: Maderazo
mesh_terms: D016470:Bacteremia / Q000097:blood* / Q000188:drug therapy / Q000382:microbiology; D001660:Biliary Tract Diseases / Q000097:blood* / Q000188:drug therapy / Q000382:microbiology; D002939:Ciprofloxacin / Q000097:blood* / Q000627:therapeutic use; D004347:Drug Interactions; D006801:Humans; D007710:Klebsiella Infections / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage*
chemical_list: D002939:Ciprofloxacin; D014580:Ursodeoxycholic Acid